Double short-time exposure to pirarubicin produces higher cytotoxicity against T24 bladder cancer cells

Journal of Infection and Chemotherapy

Volumn 17, Issue 1, 2011, Pages 11-16

  Maruyama, Takuo ^a   Higuchi, Yoshihide ^a   Suzuki, Toru ^a   Qiu, Jun ^a   Yamamoto, Shingo ^a   Shima, Hiroki ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Bladder cancer; Intravesical chemotherapy; Pirarubicin

Indexed keywords

PIRARUBICIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER CANCER; CANCER CELL; CELL CYCLE G1 PHASE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; DRUG REEXPOSURE; GROWTH INHIBITION; HISTOGRAM; IN VITRO STUDY; INTERMETHOD COMPARISON; LASER SCANNING CYTOMETRY; SHORT COURSE THERAPY;

EID: 79951557654     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-010-0088-y     Document Type: Article

References (23)

1. W Oosterlinck B Lobel G Jakse PU Malmström M Stöckle C Strenberg 2002 Guidelines on bladder cancer Eur Urol 41 105 112 10.1016/S0302-2838(01)00026-4 12074395 (Pubitemid 35428874)
2. T Miki N Nonomura Y Kojima A Okuyama E Nakano H Kiyohara, et al. 1997 A randomized study on intravesical THP (THP) chemoprophylaxis of recurrence after transurethral resection of superficial bladder cancer Hinyokika Kiyo 43 907 912 1:STN:280:DyaK1c7ltVajsA%3D%3D 9488944 (Pubitemid 28078047)
3. W Lutzeyer H Rubben H Dahm 1982 Prognostic parameters in superficial bladder cancer: an analysis of 315 cases J Urol 127 250 252 1:STN:280: DyaL387ksFKkuw%3D%3D 7062375 (Pubitemid 12131747)
4. DL Lamm FM Torti 1996 Bladder cancer, 1996 CA Cancer J Clin 46 93 112 1:STN:280:DyaK283htlGlsw%3D%3D 10.3322/canjclin.46.2.93 8624800 (Pubitemid 26095160)
5. MS Soloway M Sofer A Vaidya 2002 Contemporary management of stage T1 transitional cell carcinoma of the bladder J Urol 167 1573 1583 10.1016/S0022-5347(05)65157-9 11912367 (Pubitemid 34240678)
6. RJ Sylvester MA van der DL Lamm 2002 Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials J Urol 168 1964 1970 1:CAS:528:DC%2BD38XotFKrsLg%3D 10.1016/S0022- 5347(05)64273-5 12394686
7. C Lee MS Park 1998 Prophylactic treatment of superficial bladder tumor Int J Urol 5 511 520 1:STN:280:DyaK1M%2FntVOmuw%3D%3D 10.1111/j.1442-2042.1998. tb00404.x 9855117 (Pubitemid 29008046)
8. S Nilsson P Ragnhammar B Glimelius P Nygren 2001 A systematic overview of chemotherapy effects in urothelial bladder cancer Acta Oncol 40 371 390 1:STN:280:DC%2BD3MzovVCitw%3D%3D 10.1080/02841860151116466 11441942 (Pubitemid 32588129)
9. M Brausi L Collette K Kurth AP van der Meijden W Oosterlinck JA Witjes, et al. 2002 Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies Eur Urol 41 523 531 10.1016/S0302-2838(02)00068- 4 12074794
10. S Hinotsu H Akaza Y Ohashi T Kotake 1999 Intravesical chemotherapy for maximum prophylaxis of new early phase superficial bladder carcinoma treated by transurethral resection: a combined analysis of trials by the Japanese Urological Cancer Research Group using smoothed hazard function Cancer 86 1818 1826 1:STN:280:DC%2BD3c%2Fhs1eisw%3D%3D 10.1002/(SICI)1097-0142(19991101)86: 9<1818::AID-CNCR25>3.0.CO;2-0 10547556 (Pubitemid 29513052)
11. Y Matsumura 1990 Cooperative study of therapy of superficial bladder cancer by intravesical instillation of pirarubicin Am J Clin Oncol 13 suppl 1 S5 S10 10.1097/00000421-199012001-00003 2291459
12. Y Yamamoto Y Nasu T Saika T Akaeda T Tsushima H Kumon 2000 The absorption of pirarubicin instilled intravesically immediately after transurethral resection of superficial bladder cancer BJU Int 86 802 804 1:CAS:528: DC%2BD3cXos1OmtLc%3D 10.1046/j.1464-410x.2000.00911.x 11069404
13. T Fukushima T Ueda T Nakamura 1992 Pharmacokinetics and action mechanism of anthracyclines Gan To Kagaku Ryoho 19 445 450 1:CAS:528:DyaK38Xktl2qtrk%3D 1558393
14. H Akaza T Niijima T Hisamatsu M Fujigaki, et al. 1988 Comparative investigation on use of (2″R)-4′-O-tetrahydropyranyl-adriamycin and adriamycin as intravesical chemotherapy for superficial bladder tumors Urology 32 141 145 1:STN:280:DyaL1c3ptFWqsw%3D%3D 10.1016/0090-4295(88)90317-2 3400139
15. RJ Sylvester W Oosterlinck JA Witjes 2008 The schedule and duration of intravesical chemotherapy in patients with non-muscle-invasive bladder cancer: a systematic review of the published results of randomized clinical trials Eur Urol 53 709 719 1:CAS:528:DC%2BD1cXkvVCktbw%3D 10.1016/j.eururo.2008.01.015 18207317
16. S Maier E Reich R Martin M Bachem V Altug RE Hautmann, et al. 2000 Tributyrin induces differentiation, growth arrest and apoptosis in androgen-sensitive and androgen-resistant human prostate cancer cell lines Int J Cancer 88 245 251 1:STN:280:DC%2BD3M%2Fislamug%3D%3D 10.1002/1097- 0215(20001015)88:2<245::AID-IJC16>3.0.CO;2-X 11004676
17. NM Heney S Ahmed MJ Flanagan W Frable MP Corder MD Hafermann, et al. 1983 Superficial bladder cancer: progression and recurrence J Urol 130 1083 1086 1:STN:280:DyaL2c%2FmsV2ksg%3D%3D 6644886 (Pubitemid 14207227)
18. D Pode Y Alon AT Horowitz I Vlodavsky S Biran 1986 The mechanism of human bladder tumor implantation in an in vitro model J Urol 136 482 486 1:STN:280:DyaL283otF2nsQ%3D%3D 3525861 (Pubitemid 16070484)
19. JM Fitzpatrick AB West MR Butler V Lane JD O'Flynn, et al. 1986 Superficial bladder tumors (stage pTa, grades 1 and 2): the importance of recurrence pattern following initial resection J Urol 135 920 922 1:STN:280:DyaL287nt1Wjuw%3D%3D 3959241 (Pubitemid 16077209)
20. MS Soloway S Masters 1980 Urothelial susceptibility to tumor cell implantation: influence of cauterization Cancer 46 1158 1163 1:STN:280:DyaL3M7mt1arsA%3D%3D 10.1002/1097-0142(19800901)46:5<1158::AID- CNCR2820460514>3.0.CO;2-E 7214299 (Pubitemid 10043484)
21. O Sugano T Hatakeyama H Kato 1996 Investigation of retention time of intravesical instillation therapy with pirarubicin (THP) Gan To Kagaku Ryoho 23 1169 1174 1:STN:280:DyaK28zlsVyqsg%3D%3D 8751805 (Pubitemid 26301303)
22. S Takamoto K Ota 1986 Flow cytometric analysis of the effect of THP-adriamycin on the cell cycle traverse of RPMI-8402 cells: comparison with adriamycin Gan To Kagaku Ryoho 13 1868 1875 1:CAS:528:DyaL28Xkslaht70%3D 3707149 (Pubitemid 17219164)
23. M Tanaka S Yoshida K Kimura 1983 Mechanism of inhibition of DNA polymerases by 4′-epiadriamycin and 4′-O-tetrahydropyranyladriamycin Gann 74 829 836 1:CAS:528:DyaL2cXps1anug%3D%3D 6365674 (Pubitemid 14177406)